Back to Journals » Vascular Health and Risk Management » Volume 12

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

Total article views   HTML views PDF downloads Totals
17,002 Dovepress* 13,054+ 2,393 15,447
PubMed Central* 3,948 1,164 5,112
Totals 17,002 3,557 20,559
*Since 9 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 3 6

View citations on PubMed Central and Google Scholar